Fortrea (FTRE) Competitors $4.20 -0.49 (-10.45%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$4.24 +0.04 (+0.95%) As of 05/21/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTRE vs. PACS, WGS, NHC, TDOC, GRAL, AHCO, AGL, AVAH, VRDN, and PNTGShould you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include PACS Group (PACS), GeneDx (WGS), National HealthCare (NHC), Teladoc Health (TDOC), Grail (GRAL), AdaptHealth (AHCO), agilon health (AGL), Aveanna Healthcare (AVAH), Viridian Therapeutics (VRDN), and The Pennant Group (PNTG). These companies are all part of the "healthcare" industry. Fortrea vs. PACS Group GeneDx National HealthCare Teladoc Health Grail AdaptHealth agilon health Aveanna Healthcare Viridian Therapeutics The Pennant Group PACS Group (NYSE:PACS) and Fortrea (NASDAQ:FTRE) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk, media sentiment and community ranking. Which has higher earnings and valuation, PACS or FTRE? PACS Group has higher revenue and earnings than Fortrea. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPACS Group$3.56B0.42$112.87MN/AN/AFortrea$2.69B0.14-$3.40M-$8.79-0.48 Does the MarketBeat Community believe in PACS or FTRE? PACS Group received 12 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 95.83% of users gave PACS Group an outperform vote while only 20.00% of users gave Fortrea an outperform vote. CompanyUnderperformOutperformPACS GroupOutperform Votes2395.83% Underperform Votes14.17%FortreaOutperform Votes1120.00% Underperform Votes4480.00% Do analysts prefer PACS or FTRE? PACS Group currently has a consensus price target of $34.29, indicating a potential upside of 246.15%. Fortrea has a consensus price target of $15.00, indicating a potential upside of 257.14%. Given Fortrea's higher possible upside, analysts clearly believe Fortrea is more favorable than PACS Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PACS Group 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Fortrea 2 Sell rating(s) 12 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Is PACS or FTRE more profitable? PACS Group has a net margin of 0.00% compared to Fortrea's net margin of -10.99%. Fortrea's return on equity of 2.00% beat PACS Group's return on equity.Company Net Margins Return on Equity Return on Assets PACS GroupN/A N/A N/A Fortrea -10.99%2.00%0.80% Does the media refer more to PACS or FTRE? In the previous week, Fortrea had 6 more articles in the media than PACS Group. MarketBeat recorded 14 mentions for Fortrea and 8 mentions for PACS Group. PACS Group's average media sentiment score of 1.02 beat Fortrea's score of 0.95 indicating that PACS Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryPACS Group beats Fortrea on 9 of the 13 factors compared between the two stocks. Get Fortrea News Delivered to You Automatically Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTRE vs. The Competition Export to ExcelMetricFortreaMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$380.10M$2.92B$5.37B$8.39BDividend YieldN/A31.24%5.22%4.10%P/E Ratio-1.2312.8626.8419.71Price / Sales0.14160.59392.34117.39Price / Cash6.2857.5638.2534.62Price / Book0.214.276.794.50Net Income-$3.40M-$22.21M$3.23B$248.18M7 Day Performance-11.58%1.91%1.53%0.20%1 Month Performance-23.64%2.20%10.05%12.37%1 Year Performance-84.08%1.41%16.71%7.04% Fortrea Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTREFortrea3.3962 of 5 stars$4.20-10.4%$15.00+257.1%-84.0%$380.10M$2.69B-1.2318,000Gap DownHigh Trading VolumePACSPACS Group3.4492 of 5 stars$11.12+6.6%$34.00+205.8%-64.2%$1.69B$3.56B0.0032,433Gap UpWGSGeneDx3.9661 of 5 stars$59.00-0.2%$86.57+46.7%+226.7%$1.66B$330.14M-30.101,200Positive NewsNHCNational HealthCareN/A$102.14+1.6%N/A+5.0%$1.58B$1.37B12.8012,400Positive NewsTDOCTeladoc Health3.6831 of 5 stars$7.36+3.4%$9.71+32.0%-40.9%$1.29B$2.55B-1.275,100News CoverageAnalyst RevisionGap UpGRALGrail0.7905 of 5 stars$35.99+2.2%$26.00-27.8%N/A$1.27B$125.60M0.001,360Positive NewsGap UpAHCOAdaptHealth2.3159 of 5 stars$9.11+6.3%$13.40+47.1%-7.2%$1.23B$3.25B-5.5210,900Gap UpAGLagilon health1.9232 of 5 stars$2.97+2.6%$4.89+65.0%-57.6%$1.23B$5.99B-3.15650AVAHAveanna Healthcare0.7273 of 5 stars$5.78+7.0%$5.13-11.3%+88.0%$1.13B$2.02B-17.0033,000Insider TradeHigh Trading VolumeVRDNViridian Therapeutics2.5242 of 5 stars$13.12+5.9%$36.70+179.7%+6.1%$1.07B$302,000.00-3.0450News CoveragePositive NewsAnalyst ForecastPNTGThe Pennant Group2.8101 of 5 stars$29.55+3.4%$35.60+20.5%+20.9%$1.03B$695.24M43.465,340Positive NewsGap Up Related Companies and Tools Related Companies PACS Competitors WGS Competitors NHC Competitors TDOC Competitors GRAL Competitors AHCO Competitors AGL Competitors AVAH Competitors VRDN Competitors PNTG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTRE) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FTRE Stock Free FTRE Stock Alerts